Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein in The National Lipid Association Scientific Sessions 2025
Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk
en | boerse | 67940022 |
